Huanhuan Weng Selected Research

Human immunodeficiency virus 1 tat peptide (47-57)

1/2019

TAT peptide-modified cisplatin-loaded iron oxide nanoparticles for reversing cisplatin-resistant nasopharyngeal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huanhuan Weng Research Topics

Disease

3	Nasopharyngeal Carcinoma 01/2021 - 01/2019
2	Neoplasms (Cancer) 01/2021 - 01/2019
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2021
1	Prediabetic State (Prediabetes) 07/2015
1	Insulin Resistance 07/2015

Drug/Important Bio-Agent (IBA)

2	Peptides (Polypeptides)IBA 01/2021 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021
1	Cell-Penetrating PeptidesIBA 01/2019
1	Human immunodeficiency virus 1 tat peptide (47-57)IBA 01/2019
1	AdiponectinIBA 07/2015

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
1	Chemoradiotherapy 01/2021
1	Photothermal Therapy 01/2021
1	Lasers (Laser) 01/2021
1	Photochemotherapy (Photodynamic Therapy) 01/2021
1	Therapeutics 01/2019
1	Radiotherapy 01/2019